<DOC>
	<DOCNO>NCT01016314</DOCNO>
	<brief_summary>This multi-center , prospective randomize clinical study evaluate clinical outcome subject degenerative disc disease ( DDD ) treat ALIF supplemental posterior fixation use ASPEN Spinous Process System compare pedicle screw instrumentation .</brief_summary>
	<brief_title>Efficacy Aspen Spinous Process System Anterior Lumbar Interbody Fusion ( ALIF )</brief_title>
	<detailed_description>This multi-center , prospective randomize clinical study evaluate clinical outcome subject DDD treat ALIF supplemental posterior fixation use Aspen compare pedicle screw instrumentation . The study involve approximately 25 investigational site enroll 156 67 subject . The randomization ratio two Aspen subject one pedicle screw subject ( 2:1 ) utilize . Subjects lumbar DDD candidate ALIF single level screen inclusion study . If subject meet eligibility criterion , enrol randomize either Aspen pedicle screw group . Subjects continue follow guideline set forth clinical protocol , include : postoperative discharge exam ; six week , three month , six month , one year post-op visit ; , conclude two year post-op visit . The follow-up counted day surgery . The enrollment period expect approximately 12 month subject follow 2 year post-op duration clinical investigation . The anticipated duration study approximate 3 year .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Age 18 75 year Scheduled elective single level ALIF posterior fixation Diagnosis primary symptomatic DDD confirm appropriate imaging study and/or positive lumbar discography Oswestry Disability Index ( ODI ) v 2.1 score &gt; 30 % Failed least 6 week conservative care ( nonsurgical ) /clinical sign neurological deterioration No contraindication ASPEN spinous process system ( discretion investigator ) Prior lumbar fusion surgery level ( prior discectomy and/or laminectomy allow ) Spondylolisthesis grade 3 Lytic spondylolisthesis Incompetent miss posterior arch affect level ( e.g . laminectomy , par defect ) Currently require laminectomy level surgery Facet joint implant level absent fracture Posttraumatic vertebral body compromise acute fracture implant level Body mass Index ( BMI ) &gt; 40 Known allergy titanium Osteoporosis : SCORE ( Simple Calculated Osteoporosis Risk Estimation ) use screen subject require DEXA . Subjects Tscore &lt; 2.5 exclude Paget 's disease , osteomalacia , metabolic bone disease Use medication drug know potentially interfere bone/soft tissue healing ( e.g . chronic systemic steroid ) Planned use Bone Morphogenetic Protein ( BMP ) Unlikely comply followup evaluation schedule Subject recent history ( less 3 year ) chemical substance dependency significant psychosocial disturbance may impact outcome study participation Participation clinical trial another investigational drug device within past 30 day Systemic infection AIDS , HIV , active hepatitis Active malignancy define history invasive malignancy , except subject receive treatment display clinical sign symptom least five year Pregnant plan become pregnant length study participation Involvement active litigation relate back problem time screen Direct involvement execution protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>